Rare diseases
Investigational molecules
Locations
Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions
PolandStudy Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer
PolandStudy Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
PolandStudy on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
PolandStudy of emactuzumab compared to placebo in patients with tenosynovial giant cell tumor
PolandStudy of Inhaled Pirfenidone for Patients with Progressive Pulmonary Fibrosis
PolandStudy on Long-term Safety of Weekly Intravenous Alpha-1-Proteinase Inhibitor for Patients with Pulmonary Emphysema Due to Alpha-1-Antitrypsin Deficiency
PolandStudy on the Safety and Effectiveness of Olaparib, Ceralasertib, and AZD1775 for Patients with Metastatic Triple Negative Breast Cancer
PolandStudy on the Effects of Alpha-1-Proteinase Inhibitor for Patients with Pulmonary Emphysema Due to Alpha-1 Antitrypsin Deficiency
PolandStudy of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies
PolandStudy on the Effectiveness and Safety of Fenebrutinib and Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
PolandStudy on the Effectiveness and Safety of Rozanolixizumab for Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOG-AD)
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
